The year 2026 is set to revolutionize healthcare finance. This article delves into how MedTech innovations will drive up to 15% in cost savings, benefiting patients, providers, and payers through enhanced efficiency and improved care.

U.S. digital health investment achieved a historic milestone in Q2 2026, reaching a staggering $12 billion. This post delves into the factors fueling this growth, the innovative technologies attracting capital, and what this means for the future of healthcare.

Understand the critical 2026 tax implications for MedTech companies operating in the United States. This post offers an in-depth analysis of upcoming changes and provides actionable strategies for financial planning and compliance.

The landscape of US healthcare is rapidly evolving, with wearable technology emerging as a transformative force. This comprehensive guide for providers delves into the critical aspects of data integration from wearable devices, outlining the challenges, best practices, and future implications for patient care by 2026.

Dive into the future of MedTech employee wellness. This article unpacks 4 transformative benefits that go beyond basic health, driving retention, fostering innovation, and strengthening company culture in 2026.

The US digital health sector is experiencing unprecedented venture capital interest, with over $10 billion in funding shaping its future. This article delves into the driving forces, key investment areas, and projected landscape of digital health by 2026.

This article outlines a comprehensive 2026 educational series for US radiologists, focusing on advanced medical imaging techniques. It covers key modalities like MRI, CT, PET, and the transformative role of AI, equipping professionals with the latest knowledge for superior patient care.

Explore the crucial aspects of MedTech PTO in 2026. This comprehensive guide covers understanding your paid time off benefits, navigating company policies, and optimizing your work-life balance in the dynamic medical technology industry.

The FDA is set to release 8 new guidance documents on AI in medical devices by early 2027, signaling a pivotal shift in regulatory oversight. This article delves into the anticipated impact on manufacturers, developers, and healthcare providers, emphasizing safety, efficacy, and responsible innovation.

Navigating the financial landscape for US MedTech companies in 2026 requires a deep understanding of debt versus equity financing. This guide provides a comprehensive comparison to help drive strategic growth and innovation.